Immunotherapy for recurrent glioblastoma: practical insights and challenging prospects

por Wang, Xin, Lu, Jie, Guo, Gaochao, Yu, Jinming
Publicado 2021

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

por Wang, Xin, Guo, Gaochao, Guan, Hui, Yu, Yang, Lu, Jie, Yu, Jinming
Publicado 2019

CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway

por Wang, Xin, Lu, Jie, Li, Jing, Liu, Yang, Guo, Gaochao, Huang, Qiang
Publicado 2021

Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study

por Xue, Bingqian, Zhang, Shao, Guo, Gaochao, Wu, Ruiyu, Gu, Kaiwen, Zhao, Liming, Li, Chaoyue
Publicado 2023

IKBKE regulates cell proliferation and epithelial–mesenchymal transition of human malignant glioma via the Hippo pathway

por Lu, Jie, Yang, Yi, Guo, Gaochao, Liu, Yang, Zhang, Zhimeng, Dong, Shicai, Nan, Yang, Zhao, Zhenyi, Zhong, Yue, Huang, Qiang
Publicado 2017

Case Report: The Different Fates of Three Aneurysms: Diagnosis and Treatment Strategies for Unruptured Intracranial Aneurysms With Other Intracranial Diseases

por Guo, Gaochao, Zhao, Liming, Wu, Ruiyu, Xue, Bingqian, Zhang, Shao, Liang, Hao, Gao, Tao, Sun, Yuxue, Liu, Yang, Li, Chaoyue
Publicado 2022

Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines

por Liu, Yang, Lu, Jie, Zhang, Zhimeng, Zhu, Lin, Dong, Shicai, Guo, Gaochao, Li, Ruohong, Nan, Yang, Yu, Kai, Zhong, Yue, Huang, Qiang
Publicado 2017

Influence of Autologous Bone Marrow Stem Cell Therapy on the Levels of Inflammatory Factors and Conexin43 of Patients with Moyamoya Disease

por Zhao, Liming, Li, Tianxiao, Xue, Bingqian, Liang, Hao, Zhang, Shao, Wu, Ruiyu, Guo, Gaochao, Gao, Tao, Liu, Yang, Sun, Yuxue, Li, Chaoyue
Publicado 2022

Case Report: Curative effect of OA-PICA protected bypass in severe PICA-complicated vertebral artery stenosis treatment: Results in 3 cases

por Zhao, Liming, Xue, Bingqian, Guo, Gaochao, Wu, Ruiyu, Gao, Tao, Liu, Yang, Sun, Yuxue, Hernesniemi, Juha, Andrade Barazarte, Hugo, Li, Tianxiao, Li, Chaoyue
Publicado 2023

IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway

por Yi, Li, Guo, Gaochao, Li, Jiabo, Fan, Xiaoguang, Li, Tao, Tong, Luqing, Liu, Peidong, Wang, Xuya, Yuan, Feng, Yu, Shengping, Huang, Qiang, Yang, Xuejun
Publicado 2020

AMOTL2-knockdown promotes the proliferation, migration and invasion of glioma by regulating β-catenin nuclear localization

por Chen, Xingjie, Lu, Yalin, Guo, Gaochao, Zhang, Yu, Sun, Yan, Guo, Lianmei, Li, Ruohong, Nan, Yang, Yang, Xuejun, Dong, Jun, Jin, Xun, Huang, Qiang
Publicado 2021

Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway

por Xiong, Jinbiao, Guo, Gaochao, Guo, Lianmei, Wang, Zengguang, Chen, Zhijuan, Nan, Yang, Cao, Yiyao, Li, Ruilong, Yang, Xuejun, Dong, Jun, Jin, Xun, Yang, Weidong, Huang, Qiang
Publicado 2021

LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137

por Lu, Yalin, Guo, Gaochao, Hong, Rujun, Chen, Xingjie, Sun, Yan, Liu, Fang, Zhang, Zhimeng, Jin, Xun, Dong, Jun, Yu, Kai, Yang, Xuejun, Nan, Yang, Huang, Qiang
Publicado 2021